A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175

This study has been completed.

Sponsor:

Collaborators:

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Mental Health (NIMH)

Information provided by:

AIDS Clinical Trials Group

ClinicalTrials.gov Identifier:

NCT00096824

First received: November 15, 2004

Last updated: September 15, 2010

Last verified: September 2010

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2010
Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)

No publications provided by AIDS Clinical Trials Group

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B; 5199 study team, Silva MT, Montano S, Kanyama C, Faesen S, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Allen R, Housseinipour M, Amod F, Sanne I, Hakim J, Walawander A, Nair A; AIDS Clinical Trials Group. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis. 2012 Sep;55(6):868-76. Epub 2012 Jun 1.

To Top